Study finds potential new use for metformin

Metformin may have potential for slowing the growth of abdominal aortic aneurysms, Australian research suggests.

Use of the drug was associated with 40-87% reductions in aneurysm growth in a Queensland observational study of 1700 patients undergoing yearly surveillance for abdominal aortic aneurysms (AAA).